Table 2. Paired and multiple sequential sera from Indian and Sudanese VL and PKDL.
Country and disease status (VL or PKDL) | ||||||||
Group and sampling | India VL | India PKDL | Sudan VL | |||||
Group | 1 | 2 | 3 | 4 | 5 | 6 | 7 | Sudan |
Serum (days) | 0 and 30 | 0 and 180 | 15 and 180 | 0–30 | 0–60 | 0–180 | 0–360 | 0 and 11, 17 or 30 |
Pairs/sequentials (seq) | 24 pairs | 32 pairs | 43 pairs | 2 seq | 9 seq | 9 seq | 1 seq | 17 pairs |
Day 0 = before start of treatment.